Hacker News Reader

Drug R+D plus approval processes are very expensive both in time (>10 years) and money (>2 American billions) [1]

Don't believe everything they say. Tufts is financed by the pharmaceutical industry AND is based on data provided by the industry.

In today's world it's hard to believe there are approval processes built to take > 10 years and > $2 billion.

I would bet if these processes were carried out "transparently" we would find alot of waste and inefficiencies.

I get the feeling things will change once Silicon Valley finally decides to get more invested in the pharmaceutical industry.